POST-MARKETING SURVEILLANCE - DRUG EPIDEMIOLOGY

[1] ALLAN FN, 1976, PHILOS TECHNOLOGY DR, V7

[2] INMAN WHW, 1977, MAY EEC S DRUG SURV

[3] LAWSON DH, 1977, BRIT MED J, V1, P691, DOI 10.1136/bmj.1.6062.691

[4] SLONE D, 1977, EPIDEMIOLOGICAL EVAL

[5] WARDELL WM, 1977, DRUG MONITORING, P241

[6] POST-MARKETING SURVEILLANCE OF ADVERSE REACTIONS TO NEW MEDICINES [J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6093) : 1001 - 1003

[7] 1978, 233783007 CONTR

[8] 1980, JOINT COMMISSION PRE

[1] ALLAN FN, 1976, PHILOS TECHNOLOGY DR, V7

[2] INMAN WHW, 1977, MAY EEC S DRUG SURV

[3] LAWSON DH, 1977, BRIT MED J, V1, P691, DOI 10.1136/bmj.1.6062.691

[4] SLONE D, 1977, EPIDEMIOLOGICAL EVAL

[5] WARDELL WM, 1977, DRUG MONITORING, P241

[6] POST-MARKETING SURVEILLANCE OF ADVERSE REACTIONS TO NEW MEDICINES [J]. BRITISH MEDICAL JOURNAL, 1977, 2 (6093) : 1001 - 1003

[7] 1978, 233783007 CONTR

[8] 1980, JOINT COMMISSION PRE